Candel Therapeutics (CADL)'s 30-day implied volatility (IV30) was 67.2% at the close on October 30, 2026, down from 72.4% the day before, against a 52-week range of 37.3% to 107.9%. Its 20-day historical volatility was 66.6%.
Data as of October 30, 2026.